CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash Flows from Operating Activities:
Net income (loss)	$ 47,167	$ (55,572)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization (inclusive of depreciation included in cost of service)	12,496	11,893
Non-cash compensation	16,184	12,381
Amortization and impairment of operating lease right of use assets	17,100	16,971
(Gain) loss on disposal of property and equipment	(19)	356
Loss on personal care divestiture	0	2,186
Merger termination fee	0	106,000
Deferred income taxes	6,577	8,104
Equity in earnings from equity method investments	(2,425)	(8,114)
Amortization of deferred debt issuance costs	495	495
Return on equity method investments	718	2,753
Changes in operating assets and liabilities, net of impact of acquisitions:
Patient accounts receivable	(44,357)	7,862
Other current assets	3,127	1,689
Operating lease right of use assets	(2,069)	(1,937)
Other assets	370	244
Accounts payable	(1,693)	(4,731)
Accrued expenses	7,095	4,775
Other long-term obligations	(573)	(3,179)
Operating lease liabilities	(14,429)	(15,456)
Net cash provided by operating activities	45,764	86,720
Cash Flows from Investing Activities:
Proceeds from the sale of deferred compensation plan assets	21	25
Proceeds from the sale of property and equipment	0	100
Purchases of property and equipment	(4,055)	(2,744)
Investments in technology assets	(409)	(6,667)
Investment in equity method investee	(196)	0
Proceeds from personal care divestiture	0	47,787
Acquisitions of businesses, net of cash acquired	0	(350)
Net cash (used in) provided by investing activities	(4,639)	38,151
Cash Flows from Financing Activities:
Proceeds from issuance of stock upon exercise of stock options	0	75
Proceeds from issuance of stock under employee stock purchase plan	0	1,754
Shares withheld to pay taxes on non-cash compensation	(4,195)	(3,488)
Noncontrolling interest contributions	1,911	376
Noncontrolling interest distributions	(1,964)	(712)
Purchase of noncontrolling interest	0	(800)
Proceeds from borrowings under revolving line of credit	0	23,000
Repayments of borrowings under revolving line of credit	0	(23,000)
Principal payments of long-term obligations	(18,382)	(60,993)
Payment of accrued contingent consideration	0	(4,055)
Net cash used in financing activities	(22,630)	(67,843)
Net increase in cash, cash equivalents and restricted cash	18,495	57,028
Cash, cash equivalents and restricted cash at beginning of period	138,863	54,133
Cash, cash equivalents and restricted cash at end of period	157,358	111,161
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	15,507	13,031
Cash paid for income taxes, net of refunds received	18,393	15,820
Cash paid for operating lease liabilities	16,498	17,394
Cash paid for finance lease liabilities	7,111	5,321
Supplemental Disclosures of Non-Cash Activity:
Right of use assets obtained in exchange for operating lease liabilities	10,947	14,802
Right of use assets obtained in exchange for finance lease liabilities	10,017	27,944
Reductions to right of use assets resulting from reductions to operating lease liabilities	168	15,135
Reductions to right of use assets resulting from reductions to finance lease liabilities	$ 1,119	$ 894